Edmonton, Alberta – (April 28, 2020) – BioNeutra Global Corporation (“BioNeutra” or the “Company”) (TSXV: BGA) is providing an update on timing of the release of its financial results for the year ended December 31, 2019. As a result of COVID-19 pandemic developments, the Canadian Securities Administrators recently granted temporary relief to the Company by Alberta Securities Commission Blanket Order 51-517 (the “Blanket Relief”), from certain regulatory filings required to be made on or before June 1, 2020. The Blanket Relief provides up to a 45‐day extension for periodic filings, including financial statements and management’s discussion and analysis.
In accordance with the Blanket Relief, the Company will be delaying the filing of its audited annual consolidated financial statements for the year ended December 31, 2019, its annual management’s discussion and analysis for the corresponding period, and the related management certifications of annual filings (collectively, the “Annual Disclosure Documents”). The Company expects to be able to file the Annual Disclosure Documents on or before May 28, 2020 and confirms there have been no material business developments since the release of its third quarter results in November 2019.
Until such time as the Annual Disclosure Documents are filed, the Company’s insiders and management remain restricted from trading in the Company’s securities pursuant to the Company’s insider trading policy that reflects the principles in section 9 of National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.